Evidence map›Paper›PMID 19903932›Full record

ReviewEndocrine reviews2010

Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Zdenek Hel, Elizabeth Stringer, Jiri Mestecky

Open access · bronzeAbstract readReview
In one paragraph

Review in Endocrine reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 5 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 5 syntheses or guidelines pooled it, 167 citations in OpenAlex.

  1. Hormonal contraception for women at risk of HIV infection.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. The HIV Reservoir and Immune Landscape Across the Life Course of Women: Implications for Cure Strategies.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  15. Review
  16. Article
  17. Estrogen and viral infection.Frontiers in immunology · 2025
    Review
  18. Article
  19. Contraception in Medically Complex Adolescents and Young Adults.Open access journal of contraception · 2024
    Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zdenek HelDepartment of Pathology, University of Alabama at Birmingham, 845 19th Street South, Birmingham, Alabama 35294-2170, USA. zhel@uab.edu
Elizabeth Stringer
Jiri Mestecky
University of Alabama at Birmingham · US

Funding

Immunologic Uniqueness of the Female Genital Tract in HIV PathogenesisP01AI083027 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MESTECKY, JIRI F · 2009 to 2010
$4.0M
Dysregulation of IgA responses in HIV-1-infected individualsR01AI074438 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HEL, ZDENEK · 2007 to 2011
$2.4M
NIAID NIH HHS AI074438NIAID NIH HHS AI083027NIAID NIH HHS P01 AI083027NIAID NIH HHS R01 AI074438
6 · The paper itself

Abstract

Worldwide, an increasing number of women use oral or injectable hormonal contraceptives. However, inadequate information is available to aid women and health care professionals in weighing the potential risks of hormonal contraceptive use in individuals living with HIV-1 or at high risk of infection. Numerous epidemiological studies and challenge studies in a rhesus macaque model suggest that progesterone-based contraceptives increase the risk of HIV-1 infection in humans and simian immunodeficiency virus (SIV) infection in macaques, accelerate disease progression, and increase viral shedding in the genital tract. However, because several other studies in humans have not observed any effect of exogenously administered progesterone on HIV-1 acquisition and disease progression, the issue continues to be a topic of intense research and ongoing discussion. In contrast to progesterone, systemic or intravaginal treatment with estrogen efficiently protects female rhesus macaques against the transmission of SIV, likely by enhancing the natural protective properties of the lower genital tract mucosal tissue. Although the molecular and cellular mechanisms underlying the effect of sex steroid hormones on HIV-1 and SIV acquisition and disease progression are not well understood, progesterone and estrogen are known to regulate a number of immune mechanisms that may exert an effect on retroviral infection. This review summarizes current knowledge of the effects of various types of sex steroid hormones on immune processes involved in the biology of HIV-1 infection.

Indexed as

HIV-1AnimalsContraceptionContraceptive Agents, FemaleContraceptives, Oral, HormonalDisease ProgressionEstrogensFemaleGonadal Steroid HormonesHIV InfectionsHumansImmunomodulationProgesterone CongenersVirus SheddingContraceptive Agents, FemaleContraceptives, Oral, HormonalEstrogensGonadal Steroid HormonesProgesterone Congeners

Identifiers

PMID19903932
PMCPMC2852204
OpenAlexW2070503161

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.